|
Contents
EDITORIAL
Erratum
BioBoard
JAPAN
• New broad strain anti-influenza macrocyclic peptide therapeutic developed
LAOS
• bioCSL supports public health efforts in Laos with donation of more than 700,000 doses of seasonal influenza vaccine
SINGAPORE
• New NUS spin-off company to reduce cancer death and disease burden through real time cancer diagnosis
THAILAND
• Bats protect rice fields against pests
THE PHILIPPINES
• Hotter nights may cause rice yields to fall
• Study suggests shift in strategy on pneumonia vaccinations
BANGLADESH
• Mutant bird flu worries Bangladeshi scientists
EUROPE
• Novel strategy to molecular anticancer therapy
SRI LANKA
• Evolving dengue strains plague Sri Lanka
UNITED STATES
• Gene sequencing project discovers mutations tied to deadly brain tumors in young children
• Laboratory-grown vaginas implanted in patients
• Stem cells in circulating blood affect cardiovascular health
• New point of attack on HIV for vaccine development
• GAIM-changing molecules to combat Alzheimer鈥檚 disease and other neurodegenerative disorders discovered
• Breath analysis offers non-invasive method to detect early lung cancer
• Researchers discover new genetic brain disorder in humans
EYE ON CHINA
• WuXi PharmaTech receives honorable mention at 2014 ISPE Facility of the Year Awards
• UCLA launches joint venture with Chinese firm to open sophisticated lab in Shanghai
• Mucosis enters strategic partnership with Changchun BCHT Biotechnology of China
• Catalent enters biosimilar development collaboration with Zhejiang Hisun Pharma
• Bio-Techne acquires Shanghai PrimeGene Bio-Tech
• Sinovac receives notification of China government grant for EV71 vaccine project
• Sinovac enters technology transfer agreement with intravacc to develop and commercialize Sabin Inactivated Polio Vaccine (sIPV)
• WuXi PharmaTech breaks ground on new cell therapy manufacturing facility
• China study to see how Pacific current affects climate
• ResearchDx receives Strategic Partner Award from WuXi AppTec
• iBio receives patent allowance in China for fusion protein compositions and technology
FEATURES
• Neuroscience and the Law
• Neurological Impairment and the Capacity to Consent to Participate in Research
• Ethical Responsibility to Manage Incidental Findings in Brain Imaging Research
• The Impact of Discrimination on Research into Depression
PEOPLE WATCH
• Microchip Innovations
INSIDE INDUSTRY
• Sanaria® PfSPZ malaria vaccine wins 2014 Vaccine Industry Excellence Award for "Best Prophylactic Vaccine"
• Analytik Jena AG planning merger by absorption of CyBio AG
• Sanguine to begin work with Mayo Clinic Bioservices to accelerate individualized medicine research and development
• Thermo Fisher Scientific and the National University of Singapore Sign MOU to create strategic alliance to accelerate life science research in Singapore
• Sun Pharma to acquire Ranbaxy in a US$ 4 billion landmark transaction
• Meda and Valeant terminates joint ventures
• Crown Bioscience enters Japanese market via strategic partnership with Shin Nippon Biomedical Laboratories
• Quintiles and Biogen Idec enter comprehensive clinical development partnership
• Registration opened for Oxford Global鈥檚 Drug Discovery USA Congress
• Speakers for Oxford Global鈥檚 Microbiology & Infectious Diseases Congress released
• Daiichi Sankyo and UC San Francisco announce collaboration in drug discovery research for neurodegenerative diseases
• Funding crunch hits neglected diseases plan
• Coca-Cola partners with A*STAR to expand technology presence in Singapore
• DaVita expands kidney care services in Malaysia acquires Sinar Indentiti clinics in Seremban
• CONFERENCE CALENDAR
|
